1-5 of 5
Rachel A. Altura
Close
Sort by
Journal Articles

Novel mechanisms of PIEZO1 dysfunction in hereditary xerocytosis

Edyta Glogowska, Eve R. Schneider, Yelena Maksimova, Vincent P. Schulz, Kimberly Lezon-Geyda, John Wu, Kottayam Radhakrishnan, Siobán B. Keel, Donald Mahoney, Alison M. Freidmann, Rachel A. Altura, Elena O. Gracheva, Sviatoslav N. Bagriantsev, Theodosia A. Kalfa, Patrick G. Gallagher
Journal: Blood
Blood (2017) 130 (16): 1845–1856.
https://doi.org/10.1182/blood-2017-05-786004
Published: 2017
Includes: Multimedia, Supplemental data
Journal Articles

Lack of endothelial cell survivin causes embryonic defects in angiogenesis, cardiogenesis, and neural tube closure

Femke Zwerts, Florea Lupu, Astrid De Vriese, Saskia Pollefeyt, Lieve Moons, Rachel A. Altura, Yuying Jiang, Patrick H. Maxwell, Peter Hill, Hideyasu Oh, Claus Rieker, Désiré Collen, Simon J. Conway, Edward M. Conway
Journal: Blood
Blood (2007) 109 (11): 4742–4752.
https://doi.org/10.1182/blood-2006-06-028068
Published: 2007
Includes: Supplemental data
Journal Articles

Dissecting the role of endothelial SURVIVIN ΔEx3 in angiogenesis

Hugo Caldas, Jason R. Fangusaro, Daniel R. Boué, Michael P. Holloway, Rachel A. Altura
Journal: Blood
Blood (2006) 109 (4): 1479–1489.
https://doi.org/10.1182/blood-2006-02-003749
Published: 2006
Includes: Supplemental data
Journal Articles

Survivin-Driven Therapy for Leukemia.

Hugo Caldas, PhD, Rachel A. Altura, MD
Journal: Blood
Blood (2004) 104 (11): 2749.
https://doi.org/10.1182/blood.V104.11.2749.2749
Published: 2004
Journal Articles

The Chimeric E2A-HLF Transcription Factor Abrogates p53-Induced Apoptosis in Myeloid Leukemia Cells

Rachel A. Altura, Takeshi Inukai, Richard A. Ashmun, Gerard P. Zambetti, Martine F. Roussel, A. Thomas Look
Journal: Blood
Blood (1998) 92 (4): 1397–1405.
https://doi.org/10.1182/blood.V92.4.1397
Published: 1998